TRENTIN, LIVIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.556
AS - Asia 6.838
EU - Europa 6.600
SA - Sud America 1.204
AF - Africa 287
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 14
Totale 41.540
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.363
SG - Singapore 2.599
CN - Cina 1.921
IT - Italia 1.763
HK - Hong Kong 1.734
DE - Germania 1.289
BR - Brasile 1.067
FI - Finlandia 805
SE - Svezia 430
GB - Regno Unito 362
FR - Francia 341
RU - Federazione Russa 338
UA - Ucraina 336
PL - Polonia 312
NL - Olanda 273
IN - India 132
CI - Costa d'Avorio 94
VN - Vietnam 86
CA - Canada 83
AT - Austria 76
IE - Irlanda 72
TR - Turchia 44
BD - Bangladesh 40
AR - Argentina 37
JP - Giappone 36
IQ - Iraq 33
ES - Italia 32
MX - Messico 26
ZA - Sudafrica 25
AU - Australia 23
VE - Venezuela 23
SA - Arabia Saudita 21
BE - Belgio 19
EC - Ecuador 19
MA - Marocco 19
PK - Pakistan 17
CH - Svizzera 15
CL - Cile 15
AZ - Azerbaigian 14
RO - Romania 14
CO - Colombia 13
IL - Israele 13
JM - Giamaica 13
LT - Lituania 12
PH - Filippine 12
GR - Grecia 11
PE - Perù 11
UZ - Uzbekistan 11
AE - Emirati Arabi Uniti 10
JO - Giordania 10
LB - Libano 10
AM - Armenia 9
CR - Costa Rica 9
EG - Egitto 9
EU - Europa 9
KE - Kenya 9
TW - Taiwan 9
AD - Andorra 8
BY - Bielorussia 8
PA - Panama 8
SI - Slovenia 8
CZ - Repubblica Ceca 7
DK - Danimarca 7
ET - Etiopia 7
GT - Guatemala 7
PY - Paraguay 7
TH - Thailandia 7
TT - Trinidad e Tobago 7
BG - Bulgaria 6
GE - Georgia 6
HN - Honduras 6
IR - Iran 6
KG - Kirghizistan 6
MD - Moldavia 6
MN - Mongolia 6
MR - Mauritania 6
MU - Mauritius 6
NG - Nigeria 6
NO - Norvegia 6
PT - Portogallo 6
TN - Tunisia 6
UG - Uganda 6
UY - Uruguay 6
AO - Angola 5
BJ - Benin 5
DJ - Gibuti 5
HR - Croazia 5
KZ - Kazakistan 5
ME - Montenegro 5
NZ - Nuova Zelanda 5
RE - Reunion 5
RS - Serbia 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
BO - Bolivia 4
CD - Congo 4
CG - Congo 4
CV - Capo Verde 4
CY - Cipro 4
DO - Repubblica Dominicana 4
Totale 41.378
Salva come PNG Salva come JPEG
Città #
Fairfield 3.945
Woodbridge 2.364
Chandler 2.019
Ann Arbor 1.903
Houston 1.822
Ashburn 1.812
Hong Kong 1.730
Wilmington 1.447
Cambridge 1.414
Seattle 1.362
Singapore 1.355
Jacksonville 1.344
Boardman 719
Princeton 631
San Diego 439
Beijing 406
Santa Clara 402
Padova 389
Munich 341
Helsinki 340
Medford 336
Bytom 290
Guangzhou 261
Nanjing 258
Des Moines 254
Roxbury 170
New York 146
Milan 123
Shanghai 115
Shenyang 94
Abidjan 92
London 88
Nuremberg 76
Turku 74
Hebei 72
Dong Ket 65
Dublin 65
Los Angeles 64
Nanchang 62
São Paulo 62
Changsha 56
Jinan 55
Rome 54
Dallas 53
Jiaxing 53
Padua 53
Chicago 51
Norwalk 49
Frankfurt am Main 46
Redwood City 44
Rio de Janeiro 44
Tianjin 42
Verona 42
Lappeenranta 40
Pune 38
Bologna 32
Falkenstein 32
Vienna 32
Belo Horizonte 31
Amsterdam 28
Venice 28
Falls Church 26
Ogden 25
Washington 24
Brooklyn 23
Ottawa 21
Curitiba 20
Kharkiv 20
Kilburn 20
Phoenix 20
Tokyo 20
Brasília 19
Hefei 19
Naples 19
Paris 19
Turin 18
Düsseldorf 17
Hangzhou 17
Vicenza 17
Zhengzhou 17
Malo 16
Ningbo 16
San Francisco 16
Warsaw 16
Dhaka 15
Genoa 15
Baghdad 14
Montreal 14
Taizhou 14
Fortaleza 13
Haikou 13
Johannesburg 13
Toronto 13
Villafranca Padovana 13
Baku 12
Campinas 12
Salt Lake City 12
Brussels 11
Florence 11
Las Vegas 11
Totale 30.505
Salva come PNG Salva come JPEG
Nome #
R-Vemp Is a Safe and Effective Chemo-Immunotherapeutic Regimen In Elderly Unfit DLBCL Patients: Report From a Single Center-Experience 581
Leukaemic cells from chronic lymphocytic leukaemia patients undergo apoptosis following microtubule depolymerization and Lyn inhibition by nocodazole. 267
Direct Pharmacological Targeting of a Mitochondrial Ion Channel Selectively Kills Tumor Cells In Vivo 218
Mitochondrial apoptosis is induced by Alkoxy phenyl-1-propanone derivatives through PP2A-mediated dephosphorylation of Bad and Foxo3A in CLL 218
Prosurvival autophagy is regulated by protein kinase CK1 alpha in multiple myeloma 212
HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia 204
STAT3 mutation impacts biological and clinical features of T-LGL leukemia 198
Targeted activation of the SHP-1/PP2A signaling axis elicits apoptosis of chronic lymphocytic leukemia cells 187
Cortactin, another player in the Lyn signaling pathway, is overexpressed and alternatively spliced in leukemic cells from patients with B-cell Chronic Lymphocytic Leukemia. 180
Major infections, secondary cancers and autoimmune diseases occur in different clinical subsets of chronic lymphocytic leukaemia patients 180
The small GTPase RhoU lays downstream of JAK/STAT signaling and mediates cell migration in multiple myeloma 180
Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: A report of three cases 175
Protein kinase CK2 regulates AKT, NF-κB and STAT3 activation, stem cell viability and proliferation in acute myeloid leukemia 173
Abnormal regulation of BCR signalling by c-Cbl in chronic lymphocytic leukaemia 171
Epidemiology and risk factors of invasive fungal infections in a large cohort of patients with chronic lymphocytic leukemia 170
Role of miR-15a/miR-16-1 and TP53 axis in regulating telomerase expression in chronic lymphocytic leukemia 167
Profiling B cell chronic lymphocytic leukemia by reverse phase protein array: Focus on apoptotic proteins 165
Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cells. 163
Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis. 161
CXCR3/CXCL10 interactions in the development of hypersensitivity pneumonitis 161
Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival 159
Protein Kinase CK2 Inhibition Down Modulates the NF-κB and STAT3 Survival Pathways, Enhances the Cellular Proteotoxic Stress and Synergistically Boosts the Cytotoxic Effect of Bortezomib on Multiple Myeloma and Mantle Cell Lymphoma Cells 157
Intrinsic and extrinsic mechanisms contribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia 156
Early effects of the antineoplastic agent salinomycin on mitochondrial function 155
Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia 154
Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of SF3B1 gene refines prognosis in treatment-naïve chronic lymphocytic leukemia 153
Lyn sustains oncogenic signaling in chronic lymphocytic leukemia by strengthening SET-mediated inhibition of PP2A. 152
Rituximab-responsive CIDP 148
The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia 148
BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome 146
Selection of T lymphocyte bearing limited TCR-V beta regions in the lung of hypersensitivity pneumonitis and sarcoidosis. 144
Multiple myeloma plasma cells show different chemokine receptor profiles at sites of disease activity 143
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 143
Double autologous bone marrow transplantation and orthotopic liver transplantation in a patient with primary light chain (AL) amyloidosis. 142
Surface expression of squamous cell carcinoma antigen (SCCA) can be increased by the preS1(21-47) sequence of hepatitis B virus 141
Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia 141
Peripheral neuropathies in chronic lymphocytic leukemia: a single center experience on 816 patients. 140
Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments 140
Lack of expression of inhibitory KIR3DL1 receptor in patients with natural killer cell-type lymphoproliferative disease of granular lymphocytes 138
Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations and clinical impact 138
Lights and Shade of Next-Generation Pi3k Inhibitors in Chronic Lymphocytic Leukemia 138
Derivati dello psoralene come agenti anti-tumorali selettivi 137
Enhanced Chemokine Receptor Recycling and Impaired S1P1 Expression Promote Leukemic Cell Infiltration of Lymph Nodes in Chronic Lymphocytic Leukemia 136
In Chronic Lymphocytic Leukemia the JAK2/STAT3 Pathway Is Constitutively Activated and Its Inhibition Leads to CLL Cell Death Unaffected by the Protective Bone Marrow Microenvironment 134
Inactivation of CK1α in multiple myeloma empowers drug cytotoxicity by affecting AKT and ß-catenin survival signaling pathways 132
Towards a new age in the treatment of multiple myeloma 131
Chemokine receptor expression in EBV-associated lymphoproliferation in hu/SCID mice: implications for CXCL12/CXCR4 axis in lymphoma generation 131
Expression and role of CCR6/CCL20 chemokine axis in pulmonary sarcoidosis 131
CX-4945, a selective inhibitor of casein kinase 2, synergizes with B cell receptor signaling inhibitors in inducing diffuse large B cell lymphoma cell death 130
Splenic marginal zone lymphoma with a de novo t(8;14)(q24;q32) and a prolymphocytoid evolution responsive to rituximab-bendamustine 129
Geldanamycin-induced Lyn dissociation from aberrant Hsp90-stabilized cytosolic complex is an early event in apoptotic mechanisms in B-chronic lymphocytic leukemia. 128
Pulmonary alveolar macrophages from patients with active sarcoidosis express type IV collagenolytic activity: an enzymatic mechanism for influx of mononuclear phagocytes at site of disease activity 127
Modulation of ER Stress/Unfolded Protein Response (UPR) Pathways in Multiple Myeloma Cells by Inhibition of Hsp90 and Serine-Threonine Kinase CK2. 127
p66Shc deficiency enhances CXCR4 and CCR7 recycling in CLL B cells by facilitating their dephosphorylation-dependent release from β-arrestin at early endosomes 126
Early chemotherapy intensification with escalated beacopp in patients with advanced-stage hodgkin lymphoma with a positive interim positron emission tomography/computed tomography scan after two abvd cycles: Long-term results of the GITIL/FIL HD 0607 trial 126
Obinutuzumab, a new anti-CD20 antibody, and chlorambucil are active and effective in anti-MAG antibody polyneuropathy 125
Cytogenetic Impact on Lenalidomide Treatment in Relapsed/Refractory Multiple Myeloma: A Real-Life Evaluation 124
Detection of monoclonal T populations in patients with KIR-restricted chronic lymphoproliferative disorder of NK cells. 124
Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity 124
CXCR3/CXCL10 interactions in the development of hypersensitivity pneumonitis 124
Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficiencies 124
Idelalisib plus rituximab is effective in systemic AL amyloidosis secondary to chronic lymphocytic leukaemia 124
SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection 123
Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations 122
Antiapoptotic effects of IL-15 on pulmonary Tc1 cells of patients with human immunodeficiency virus infection 121
Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes 121
Hexokinase 2 displacement from mitochondria‐associated membranes prompts Ca 2+ ‐dependent death of cancer cells 121
Role of hematopoietic-specific protein 1 (HS1) in apoptosis in B-chronic lymphocytic leukemia. 120
Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia. 120
Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events 119
Immunologic abnormalities in angioimmunoblastic lymphadenopathy. 119
HS1, a Lyn Kinase Substrate, Is Abnormally Expressed in B-Chronic Lymphocytic Leukemia and Correlates with Response to Fludarabine-Based Regimen. 119
Dabigatran in ibrutinib-treated patients with atrial fibrillation and lymphoproliferative diseases: Experience of 4 cases 119
Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission. 119
Lyn-mediated procaspase 8 dimerization blocks apoptotic signaling in B-cell chronic lymphocytic leukemia. 119
Effects of CK2 inhibition on multiple signaling pathways in myeloma cells. 118
Extracorporeal photochemotherapy may improve outcome in children with acute GVHD. 118
Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death 118
Ibrutinib in relapsed hairy cell leukemia variant: a case report and review of the literature 118
CLL patients carrying 13q deletion show clinical heterogenity according to IGVH mutational status and CD38 expression 118
CD40 activation of B-CLL cells is associated with augmented intracellular levels of CD79b and increased BCR expression in a subset of patients 117
Role for CXCR6 and its ligand CXCL16 in the pathogenesis of T-cell alveolitis in sarcoidosis 117
Ibrutinib Therapy Releases Leukemic Surface IgM from Antigen Drive in Chronic Lymphocytic Leukemia Patients 117
T-cell type lymphoproliferative disease of granular lymphocytes (LDGL) is equipped with a phenotypic pattern typical of effector cytotoxic cells 115
Analysis of KIR framework loci in patients with NK-type lymphoproliferative disease of granular lymphocytes (LDGL) 115
SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection 115
Lyn-mediated SHP-1 recruitment to CD5 contributes to resistance to apoptosis of B-cell chronic lymphocytic leukemia cells. 115
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL 115
Squamous cell carcinoma antigen (SCCA) expression and CD27+ memory B lymphocytes in patients with chronic hepatitis C 114
Alveolar macrophages from patients with HIV-1 infection constitutively synthesize and release tumor necrosis factor-alfa. 114
Role of protein kinase CK2 in the retinoic acid-induced differentiation of acute promyelocytic leukemia cells. 113
Genotypic evaluation of killer immunoglobulin-like receptors in NK-type lymphoproliferative disease of granular lymphocytes 113
Clinical profile associated with infections in patients with chronic lymphocytic leukemia. Protective role of immunoglobulin replacement therapy 113
Intrinsic and Estrinsic Mechanism Contributes to Maintain the JAK/STAT Pathway Aberrantly Activated in T-Type Large Granular Lymphocyte Leukemia 113
Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia 113
Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes 112
Biophysical Characterization and Expression Analysis of Kv1.3 Potassium Channel in Primary Human Leukemic B Cells 112
CD8+ T lymphocytes in the lung of AIDS patients harbor Human Immunodeficiency Virus Type 1. 111
Gene expression signatures of pediatric myelodysplastic syndromes are associated with risk of evolution into acute myeloid leukemia 111
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study 111
Totale 14.329
Salva come PNG Salva come JPEG
Categoria #
all - tutte 169.248
article - articoli 153.937
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 443
selected - selezionate 0
volume - volumi 2.977
Totale 326.605
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215.089 324 406 269 437 115 275 345 472 712 763 556 415
2021/20225.702 174 682 646 468 271 263 267 615 343 128 582 1.263
2022/20234.472 953 401 90 565 688 549 50 313 477 54 240 92
2023/20242.793 111 297 247 191 218 318 160 134 83 394 310 330
2024/202511.190 78 790 550 405 1.263 318 534 908 1.099 489 1.843 2.913
2025/2026420 420 0 0 0 0 0 0 0 0 0 0 0
Totale 42.117